Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.06 USD | +0.98% | +5.64% | +3.52% |
05-14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
05-13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.52% | 35.44M | |
+23.92% | 88.22B | |
-22.14% | 76.5B | |
+1.76% | 26.97B | |
+7.94% | 18.61B | |
-13.19% | 16.72B | |
+3.25% | 15.85B | |
+75.93% | 13.41B | |
+77.27% | 13.16B | |
+22.95% | 12.67B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Earnings Flash (XGN) EXAGEN Reports Q4 Revenue $12.8M, vs. Street Est of $8.7M